Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 170
TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200905(US9533999, i-39)
Affinity DataIC50: 39nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019905(CHEMBL3287210 | US9533999, ii-4)
Affinity DataIC50: 41nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200937(US9533999, ii-5)
Affinity DataIC50: 46nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200946(US9533999, ii-8)
Affinity DataIC50: 47nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019903(CHEMBL3287208 | US9533999, i-40)
Affinity DataIC50: 48nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019900(CHEMBL3287205 | US9533999, i-5)
Affinity DataIC50: 49nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200942(US9533999, ii-7)
Affinity DataIC50: 52nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019904(CHEMBL3287209 | US9533999, ii-1)
Affinity DataIC50: 52nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200966(US9533999, ii-17)
Affinity DataIC50: 60nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019906(CHEMBL3287211 | US9533999, ii-11)
Affinity DataIC50: 66nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200973(US9533999, ii-23)
Affinity DataIC50: 67nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200904(US9533999, i-38)
Affinity DataIC50: 71nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200971(US9533999, ii-22)
Affinity DataIC50: 73nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200855(US9533999, i-12)
Affinity DataIC50: 77nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200862(US9533999, i-18)
Affinity DataIC50: 88nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200858(US9533999, i-15)
Affinity DataIC50: 92nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM50019901(CHEMBL3287206 | US9533999, i-34)
Affinity DataIC50: 96nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200852(US9533999, i-9)
Affinity DataIC50: 110nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200894(US9533999, i-33)
Affinity DataIC50: 110nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200930(US9533999, i-43)
Affinity DataIC50: 120nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200840(US9533999, i-2)
Affinity DataIC50: 120nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200947(US9533999, ii-9)
Affinity DataIC50: 130nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200842(US9533999, i-4)
Affinity DataIC50: 140nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200929(US9533999, i-42)
Affinity DataIC50: 150nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200955(US9533999, ii-13)
Affinity DataIC50: 160nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200870(US9533999, i-23)
Affinity DataIC50: 170nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200965(US9533999, ii-16)
Affinity DataIC50: 170nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200841(US9533999, i-3)
Affinity DataIC50: 180nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200853(US9533999, i-10)
Affinity DataIC50: 180nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200935(US9533999, ii-3)
Affinity DataIC50: 180nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200923(US9533999, i-41)
Affinity DataIC50: 190nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200900(US9533999, i-37)
Affinity DataIC50: 230nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200896(US9533999, i-35)
Affinity DataIC50: 240nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200865(US9533999, i-21)
Affinity DataIC50: 240nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200967(US9533999, ii-18)
Affinity DataIC50: 250nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200952(US9533999, ii-12)
Affinity DataIC50: 260nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200839(US9533999, i-1)
Affinity DataIC50: 290nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200879(US9533999, i-27)
Affinity DataIC50: 310nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200948(US9533999, ii-10)
Affinity DataIC50: 310nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200933(US9533999, ii-2)
Affinity DataIC50: 320nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200968(US9533999, ii-19)
Affinity DataIC50: 340nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200861(US9533999, i-17)
Affinity DataIC50: 350nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200846(US9533999, i-7)
Affinity DataIC50: 350nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200899(US9533999, i-36)
Affinity DataIC50: 380nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200970(US9533999, ii-21)
Affinity DataIC50: 400nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200864(US9533999, i-20)
Affinity DataIC50: 490nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200964(US9533999, ii-15)
Affinity DataIC50: 490nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200874(US9533999, i-26)
Affinity DataIC50: 510nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200969(US9533999, ii-20)
Affinity DataIC50: 510nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

TargetIntermediate conductance calcium-activated potassium channel protein 4(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM200856(US9533999, i-13)
Affinity DataIC50: 830nMAssay Description:HEK293 cells over-expressing human KCa3.1 are used to measure the effects of compounds in inhibiting the KCa3.1 channel function. The assay is based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: